Screening and Identification of ESR1 as a Target of Icaritin in Hepatocellular Carcinoma: Evidence from Bibliometrics and Bioinformatic Analysis

鉴定(生物学) 肝细胞癌 文献计量学 生物 计算生物学 医学 植物 计算机科学 遗传学 图书馆学
作者
Yinghui Zhou,Jiafeng Gu,Haoran Yu,Fengyang Chen,Chao Long,Maiweilan Maihemuti,Tingsong Chen,Wei Zhang
出处
期刊:Current Molecular Pharmacology [Bentham Science]
卷期号:17
标识
DOI:10.2174/0118761429260902230925044009
摘要

In 2022, icaritin a Traditional Chinese Medicine with estrogen-like activities was recommended by the CSCO guidelines as a systematic treatment for patients with advanced HCC due to its clinical safety and efficacy. However the mechanism and targets of icaritin are unclear. In this study we aimed to reveal the target of icaritin in HCC.First literature related to icaritin was downloaded from the Web of Science. The software programs "Rstudio" "VOSviewer" and "Mendeley Desktop" were used to analyze the distribution of icaritin publications and research hotspots. Meanwhile icaritin-related genes were obtained by combining them with the PubChem database. Second transcriptome data of HCC patients were obtained from the TCGA database. The proteinprotein interaction (PPI) analysis of icaritin-related genes was performed using the String data platform and the visualization and network topology analysis were performed using Cytoscape. Cox regression analyses were combined to screen the hub target and verified it through cell experiments.A total of 239 icaritin-related articles were obtained HCC is a new hotspot in the icaritin field. 292 icaritin-related genes were obtained and a core module containing 34 genes was obtained by module division. Among them ESR1 was an independent prognostic factor. Molecular docking showed that ESR1 and icaritin had a high affinity. Functional studies revealed that ESR1 inhibits HCC cell malignant proliferation and improves the sensitivity of HCC cells to icaritin.We propose that ESR1 as a target of icaritin may be conducive to improving icaritin therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
我是老大应助XZN采纳,获得10
2秒前
Ava应助红泥小火炉采纳,获得10
3秒前
科研通AI2S应助务实大神采纳,获得10
3秒前
xixi发布了新的文献求助10
4秒前
顾矜应助狼牙采纳,获得10
5秒前
gttlyb完成签到,获得积分10
6秒前
CodeCraft应助玻璃杯采纳,获得10
6秒前
6秒前
zhzh完成签到,获得积分10
6秒前
lzb发布了新的文献求助10
8秒前
万能图书馆应助南风采纳,获得10
9秒前
小蘑菇应助wuyongmei采纳,获得10
10秒前
younger发布了新的文献求助10
10秒前
逢场作戱__完成签到 ,获得积分10
10秒前
11秒前
12秒前
贝肯尼完成签到,获得积分10
14秒前
14秒前
郭盾发布了新的文献求助10
14秒前
小马发布了新的文献求助10
16秒前
英俊清涟完成签到,获得积分10
16秒前
狼牙发布了新的文献求助10
17秒前
younger完成签到,获得积分10
19秒前
lg2发布了新的文献求助10
19秒前
小白大当家完成签到,获得积分10
20秒前
20秒前
loricae2005完成签到,获得积分10
21秒前
26秒前
mei的科研小院子完成签到,获得积分10
26秒前
在水一方应助wuyongmei采纳,获得10
27秒前
伶俜完成签到,获得积分10
27秒前
28秒前
酷炫觅松发布了新的文献求助10
29秒前
伶俜发布了新的文献求助10
30秒前
30秒前
32秒前
34秒前
34秒前
ding应助科研通管家采纳,获得10
34秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger Heßler, Claudia, Rud 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 1000
Natural History of Mantodea 螳螂的自然史 1000
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
How Maoism Was Made: Reconstructing China, 1949-1965 800
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 量子力学 冶金 电极
热门帖子
关注 科研通微信公众号,转发送积分 3321819
求助须知:如何正确求助?哪些是违规求助? 2953110
关于积分的说明 8564033
捐赠科研通 2630614
什么是DOI,文献DOI怎么找? 1439256
科研通“疑难数据库(出版商)”最低求助积分说明 667057
邀请新用户注册赠送积分活动 653495